Please login to the form below

Not currently logged in
Email:
Password:

Forbion

This page shows the latest Forbion news and features for those working in and with pharma, biotech and healthcare.

VC raises new €270m fund for European biotechs

VC raises new €270m fund for European biotechs

Life sciences venture capital company Forbion has raised 270m in funding for European biotechs, in a sign that investment cash is returning to the sector. ... Forbion IV is a step up from its last fund, which raised 183m in 2016 with 70% earmarked for

Latest news

  • Amakem raises €18m for glaucoma treatment

    In connection with this financing round Christina Takke (Forbion Capital Partners), Emmanuelle Coutanceau (Crédit Agricole Private Equity) and Gaston Matthyssens (Vesalius BioCapital) will join Amakem's board. ... Meanwhile Geert-Jan Mulder (Forbion

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics